Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Viability of an E. Coli Nissle Colibactin Knockout in Healthy Volunteers

NCT05816577 is registered in ClinicalTrials.gov with Max Nieuwdorp as lead sponsor.

NCT NCT05816577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05816577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Viability of an E. Coli Nissle Colibactin Knockout in Healthy Volunteers
Lead sponsor
Max Nieuwdorp
Phase
Phase 1
Overall status
Completed
Start date
September 18, 2023
Completion date
March 19, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes